Jade Biosciences (JBIO) Current Leases (2021 - 2025)
Jade Biosciences posted quarterly Current Leases of $312000.0 for Q1 2025, down 29.89% year-on-year from $445000.0 in Q1 2024, and down 25.18% on a QoQ basis from $417000.0 in Q4 2024.
Jade Biosciences (JBIO) has 5 years of Current Leases data on file, last reported at $312000.0 in Q1 2025.
- For the quarter ending Q1 2025, Current Leases fell 29.89% year-over-year to $312000.0; the trailing twelve-month figure through Mar 2025 stood at $312000.0 (down 29.89% YoY), and the FY2024 full-year result was $417000.0, down 0.71% from the prior year.
- Current Leases for Q1 2025 stood at $312000.0, down from $417000.0 in the prior quarter.
- Across five years, Current Leases topped out at $475000.0 in Q2 2024 and bottomed at $147000.0 in Q3 2021.
- The 5-year median for Current Leases is $379000.0 (2022), against an average of $358266.7.
- The widest annual swing landed in 2022, when Current Leases jumped 157.82%; it then declined 29.89% in 2025.
- A 5-year view of Current Leases shows it stood at $192000.0 in 2021, then soared by 100.52% to $385000.0 in 2022, then rose by 9.09% to $420000.0 in 2023, then dropped by 0.71% to $417000.0 in 2024, then declined by 25.18% to $312000.0 in 2025.
- The last three Current Leases figures came in at $312000.0 (Q1 2025), $417000.0 (Q4 2024), and $459000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 312,000.00 |
| Dec 31, 2024 | 417,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 420,000.00 |
| Sep 30, 2023 | 451,000.00 |
| Jun 30, 2023 | 379,000.00 |
| Mar 31, 2023 | 373,000.00 |
| Dec 31, 2022 | 385,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 347,000.00 |
| Mar 31, 2022 | 193,000.00 |
| Dec 31, 2021 | 192,000.00 |
| Sep 30, 2021 | 147,000.00 |